Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/744825/000162828019010692/ams06-30x201910q.htm
• | Total revenue in the second quarter was $5,197,000, a 0.5% increase vs. comparable period in 2018. Proton therapy revenue of $1,409,000 increased 3.4% quarter over quarter. Gamma Knife revenue of $3,600,000 increased 0.2% quarter over quarter due to a contractual adjustment related to Medicare reimbursement at one of the Company’s existing sites. |
• | Total proton therapy fractions in the second quarter increased 8.6% quarter over quarter. The increase for the second quarter was the result of continuing increased awareness of the benefits of proton therapy treatment. |
• | Net income in the second quarter was $31,000 vs. $287,000 in the comparable period in 2018. The decrease in net income was due to increased operating expense and selling and administrative costs. |
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by American Shared Hospital Services.
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/744825/000162828019010692/ams06-30x201910q.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years